Table 3 Addition of select respondent demographics to model predicting choosing to decline active therapy

X1 (further treatment)

1 week

Reference

4 weeks

1.28 (0.08)*

7 weeks

1.70 (0.12)*

X2 (chance of death)

Low risk (20%)

Reference

Moderate risk (50%)

1.20 (0.06)*

High risk (80%)

2.02 (0.15)*

X3 (memory and concentration)

Low risk (20%)

Reference

Moderate risk (50%)

1.70 (0.09)*

High risk (80%)

4.03 (0.30)*

X4 (care assistance)

Low risk (20%)

Reference

Moderate risk (50%)

1.66 (0.11)*

High risk (80%)

4.19 (0.32)*

X5 (residential care)

Low risk (20%)

Reference

Moderate risk (50%)

1.91 (0.11)*

High risk (80%)

6.54 (0.53)*

Gender

Male

Reference

Female

1.38 (0.17)*

Children under 5

No

Reference

Yes

0.58 (0.08)*

Children 15–18

No

Reference

Yes

0.64 (0.08)*

Constant

0.11 (0.02)*

Pseudo R²

0.164